Search

Search Results
Results 861 - 870 of 889 for Chronic fatigue syndrome
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Azarga (Brinzolamide 10 mg/mL and timolol 5 mg/mL) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Symtuza (Darunavir/cobicistat/emtricitabine/tenofovir alafenamide) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Glypressin Solution intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Sprycel intended for persons living in Australia.
  • Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor (Ethinylestradiol and Norethisterone) intended for persons living in Australia.
  • Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor-1 (Ethinylestradiol and Norethisterone) intended for persons living in Australia.
  • Drug - 23 Dec 2022
    Consumer Medicine Information (CMI) about Telzir Tablets intended for persons living in Australia.
  • Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Kiovig intended for persons living in Australia.
  • Drug - 17 Oct 2022
    Consumer Medicine Information (CMI) about Ribomustin (Bendamustine Hydrochloride) intended for persons living in Australia.
  • Drug - 8 Sep 2022
    Consumer Medicine Information (CMI) about Rixadone (risperidone) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.